JBIO

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Jade Biosciences, Inc.

NASDAQ | JBIO

12.82

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 28, 2025)

$280.13M

Market Cap

-

P/E Ratio

-

EPS

$97.54

52 Week High

$6.57

52 Week Low

HEALTHCARE

Sector

JBIO Chart

Recent Chart
Price Action

JBIO Technicals

Tags:

JBIO Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (None)
Gross Profit -$282K
Total Revenue -
Cost Of Revenue $282K
Costof Goods And Services Sold $282K
Operating Income -$75M
Selling General And Administrative $8.6K
Research And Development $53M
Operating Expenses $74M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $282K
Income Before Tax -$70M
Income Tax Expense $55K
Interest And Debt Expense -
Net Income From Continuing Operations -
Comprehensive Income Net Of Tax -
Ebit -$70M
Ebitda -$69M
Net Income -$70M

Revenue & Profitability

Earnings Performance

JBIO Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (None)
Total Assets $80M
Total Current Assets $80M
Cash And Cash Equivalents At Carrying Value $34M
Cash And Short Term Investments $34M
Inventory -
Current Net Receivables -
Total Non Current Assets $215K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $45M
Other Current Assets $1.5M
Other Non Current Assets -
Total Liabilities $3.9M
Total Current Liabilities $3.8M
Current Accounts Payable $224K
Deferred Revenue -
Current Debt -
Short Term Debt $417K
Total Non Current Liabilities $70K
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $417K
Other Current Liabilities $3.2M
Other Non Current Liabilities -
Total Shareholder Equity $76M
Treasury Stock -
Retained Earnings -$233M
Common Stock $3K
Common Stock Shares Outstanding $817K

yearly Cash Flow (As of Dec 31, 2024)

Field Value (None)
Operating Cashflow -$71M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $282K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $56M
Cashflow From Financing $25M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$70M

yearly Income Statement (As of Dec 31, 2024)

Field Value (None)
Gross Profit -$282K
Total Revenue -
Cost Of Revenue $282K
Costof Goods And Services Sold $282K
Operating Income -$75M
Selling General And Administrative $8.6K
Research And Development $53M
Operating Expenses $74M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $282K
Income Before Tax -$70M
Income Tax Expense $55K
Interest And Debt Expense -
Net Income From Continuing Operations -
Comprehensive Income Net Of Tax -
Ebit -$70M
Ebitda -$69M
Net Income -$70M

Dividends

Field Value
Ex Dividend Date 2025-04-25
Declaration Date 2025-04-09
Record Date 2025-04-25
Payment Date 2025-04-29
Amount 2.4

JBIO News

JBIO Profile

Jade Biosciences, Inc. Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Jade Biosciences, Inc. is an innovative biotechnology company based in Waltham, Massachusetts, dedicated to developing pioneering therapies for inflammatory and immunological disorders, especially autoimmune diseases. The company leverages a robust proprietary drug development pipeline supported by cutting-edge research to address critical unmet medical needs. By focusing on transformative immunotherapy solutions, Jade Biosciences is strategically positioned to significantly enhance treatment options and patient outcomes in this vital sector of healthcare.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
KTTA
+38.67%
$1.47
NVDA
-1.80%
$177.00
VINE
+10.76%
$0.39
HBI
-1.82%
$6.47
AMZE
+19.82%
$0.47
TLRY
-21.06%
$0.81
INTC
+10.18%
$40.56
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
ASST
+1.80%
$1.13
YGMZ
-9.59%
$0.11
BYND
-3.74%
$0.98
AXDX
-61.36%
$0.03
BMNR
+4.53%
$33.18
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
RUBI
-26.17%
$0.15
KVUE
+1.11%
$17.22
PLUG
+1.51%
$2.01
SOND
-23.45%
$0.12
SNAP
+0.72%
$7.66
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
AAL
+0.86%
$14.05
BIYA
+17.05%
$0.29
INHD
-0.97%
$0.22
TSLA
+0.84%
$430.17
CHR
-3.48%
$0.04
SRM
+53.27%
$10.30
CIFR
+6.26%
$20.35
ONMD
+30.28%
$1.85
IVP
-20.80%
$0.13
BMNU
+8.77%
$8.18
ONDS
-4.12%
$7.90
MARA
+6.30%
$11.81
WULF
+4.51%
$15.51
NIO
+0.82%
$5.50
F
+0.45%
$13.25
TWOH
0.00%
$0.00
WLGS
-5.57%
$0.04
BURU
+10.43%
$0.24
GPUS
-8.58%
$0.30
MTSR
-0.35%
$70.50
VALE
+0.79%
$12.61
SOFI
+4.31%
$29.72
UPWK
-0.55%
$19.58
GOOGL
+0.07%
$320.18
BTBT
+2.58%
$2.38
DEFT
+9.35%
$1.52
ADTX
+21.01%
$3.80
BTG
+3.80%
$4.64
GRAB
+2.44%
$5.45
ACHR
+4.40%
$7.82
AFMD
-34.94%
$0.18
DVLT
-4.69%
$2.03
PFE
0.00%
$25.71
SMX
+250.80%
$61.04
CRCL
+10.02%
$79.92
PLTZ
-2.62%
$7.43
KWM
+13.63%
$0.75
DNN
-0.19%
$2.55
IBRX
+10.79%
$2.36
RIOT
+7.82%
$16.13
VEEE
+45.50%
$2.59
AMZN
+1.77%
$233.22
AAPL
+0.46%
$278.85
CAN
+9.78%
$1.01
WBD
+0.50%
$24.00
AIIO
-9.09%
$0.70
AG
+12.65%
$15.22
APLD
+8.66%
$27.10
GOOG
-0.05%
$320.12
NGD
+6.76%
$8.37
IREN
-1.32%
$47.81
RIG
+2.09%
$4.39
GRYP
-10.38%
$1.38
BAC
+1.28%
$53.67
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
RIVN
+4.20%
$16.86
SMR
+5.04%
$20.00
TMC
+19.38%
$6.96
PLTR
+1.61%
$168.45
CDE
+6.76%
$17.28
ITUB
+1.82%
$7.80
AGNC
-0.66%
$10.49
NAKA
+7.20%
$0.49
KDLY
+7.20%
$0.49
CRCA
+19.56%
$4.40
T
+0.69%
$26.00
AMC
+6.30%
$2.44
NVO
+1.21%
$49.30
CRCG
+20.00%
$2.82
MSTR
+0.87%
$177.18
NFLX
+1.35%
$107.58
SAND
-6.04%
$12.12
BBD
+0.67%
$3.70
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
KTTA
+38.67%
$1.47
NVDA
-1.80%
$177.00
VINE
+10.76%
$0.39
HBI
-1.82%
$6.47
AMZE
+19.82%
$0.47
TLRY
-21.06%
$0.81
INTC
+10.18%
$40.56
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
ASST
+1.80%
$1.13
YGMZ
-9.59%
$0.11
BYND
-3.74%
$0.98
AXDX
-61.36%
$0.03
BMNR
+4.53%
$33.18
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
RUBI
-26.17%
$0.15
KVUE
+1.11%
$17.22
PLUG
+1.51%
$2.01
SOND
-23.45%
$0.12
SNAP
+0.72%
$7.66
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
AAL
+0.86%
$14.05
BIYA
+17.05%
$0.29
INHD
-0.97%
$0.22
TSLA
+0.84%
$430.17
CHR
-3.48%
$0.04
SRM
+53.27%
$10.30
CIFR
+6.26%
$20.35
ONMD
+30.28%
$1.85
IVP
-20.80%
$0.13
BMNU
+8.77%
$8.18
ONDS
-4.12%
$7.90
MARA
+6.30%
$11.81
WULF
+4.51%
$15.51
NIO
+0.82%
$5.50
F
+0.45%
$13.25
TWOH
0.00%
$0.00
WLGS
-5.57%
$0.04
BURU
+10.43%
$0.24
GPUS
-8.58%
$0.30
MTSR
-0.35%
$70.50
VALE
+0.79%
$12.61
SOFI
+4.31%
$29.72
UPWK
-0.55%
$19.58
GOOGL
+0.07%
$320.18
BTBT
+2.58%
$2.38
DEFT
+9.35%
$1.52
ADTX
+21.01%
$3.80
BTG
+3.80%
$4.64
GRAB
+2.44%
$5.45
ACHR
+4.40%
$7.82
AFMD
-34.94%
$0.18
DVLT
-4.69%
$2.03
PFE
0.00%
$25.71
SMX
+250.80%
$61.04
CRCL
+10.02%
$79.92
PLTZ
-2.62%
$7.43
KWM
+13.63%
$0.75
DNN
-0.19%
$2.55
IBRX
+10.79%
$2.36
RIOT
+7.82%
$16.13
VEEE
+45.50%
$2.59
AMZN
+1.77%
$233.22
AAPL
+0.46%
$278.85
CAN
+9.78%
$1.01
WBD
+0.50%
$24.00
AIIO
-9.09%
$0.70
AG
+12.65%
$15.22
APLD
+8.66%
$27.10
GOOG
-0.05%
$320.12
NGD
+6.76%
$8.37
IREN
-1.32%
$47.81
RIG
+2.09%
$4.39
GRYP
-10.38%
$1.38
BAC
+1.28%
$53.67
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
RIVN
+4.20%
$16.86
SMR
+5.04%
$20.00
TMC
+19.38%
$6.96
PLTR
+1.61%
$168.45
CDE
+6.76%
$17.28
ITUB
+1.82%
$7.80
AGNC
-0.66%
$10.49
NAKA
+7.20%
$0.49
KDLY
+7.20%
$0.49
CRCA
+19.56%
$4.40
T
+0.69%
$26.00
AMC
+6.30%
$2.44
NVO
+1.21%
$49.30
CRCG
+20.00%
$2.82
MSTR
+0.87%
$177.18
NFLX
+1.35%
$107.58
SAND
-6.04%
$12.12
BBD
+0.67%
$3.70
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.